Skip to main content
Category

News Archive

tissue-analytics-logo

A Baltimore health-tech startup wants to upgrade doctors’ tools for wound care – Baltimore Business Journal

By News Archive

tissue-analytics-logo

Bedsores, diabetic ulcers and other chronic wounds cost the U.S. health care system $30 billion a year. Why? At least in part because the primary tool doctors and nurses use to track wounds is a basic ruler.

A ruler can measure the size of a wound, but does little to track other important qualities, such as changes in shape and tissue color. Consider that patients are usually cared for by a rotating team of nurses, who may each interpret a wound’s appearance differently, and it’s easier to see how so much money is spent tending to preventable (or at least treatable) conditions.

Read More
pieris-logo

Pieris Initiates Phase I Clinical Trial for Anticalin(R) to Treat Anemia – Yahoo Finance

By News Archive

pieris-logo

Pieris AG announced today the initiation of a Phase I clinical trial with PRS-080, an anti-hepcidin Anticalin® therapeutic protein designed to treat anemia. The trial is a placebo-controlled, single ascending dose evaluation of the compound’s safety and tolerability in healthy volunteers. Conducted in Germany, the trial is underway and patients from the first cohort have been dosed.

Read More
nhlbi-logo-new.png

NHLBI Funding & Research Opportunities and Announcements for December 8, 2014

By News Archive

nhlbi-logo-new.png

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

  • Request for Comments on the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
  • Reminder for the Extramural Scientific Community: Implementation of the Genomic Data Sharing Policy Begins January 25, 2015
  • Notice of Office of Laboratory Animal Welfare Policy on Shared Animal Welfare Concerns
  • NIH Modification to Guidance on Marking Changes in Resubmission Applications
  • Update: New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or After May 25, 2015
  • Notice of NHGRI Participation in PA-14-015 “Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)” and Establishment of New Training Program in the Ethical, Legal and Social Implications of Genetic and Genomic Research
  • Notice of Additional Due Date and Correction for RFA-HG-14-005 “Revisions to Add Biomedical Big Data Training to Active Institutional Training Grants (T32)”
  • Notice of Change to Instructions for Senior/Key Personnel in the Overall and Project Components of PAR-13-316 “NHLBI Program Project Applications (P01)” 
  • Request for Information (RFI): Challenges and Opportunities for Exploring and Understanding the Epitranscriptome

Requests for Applications:

  • Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R41)
    • (RFA-HL-15-026)
    • National Heart, Lung, and Blood Institute
    • Application Receipt Date(s): February 9, 2015 and November 9, 2015
  • Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R43/R44)
    • (RFA-HL-15-027)
    • National Heart, Lung, and Blood Institute
    • Application Receipt Date(s): February 9, 2015; November 9, 2015; and November 9, 2016

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.